Psychiatry · Gary, IN
NPI
1912970229
Since 2006
Specialty
Psychiatry
Code 2084P0800X
Group practices
2
Medicare group memberships
Hospitals
1
Hospital affiliations
1100 W 6th Ave
Gary, IN, 46402
Phone (219) 885-4264
Groups this clinician bills Medicare through
Medicare paid, 2024
$8,196
260 services
Medicare patients, 2024
57
Average age 50
Drug cost, 2024
$3.2M
5,821 prescriptions
Company payments, 2025
$376
From 11 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Mathew V Castelino was code 96372 (injection administration), 108 times for 21 patients. In total Mathew V Castelino billed 260 services in 8 codes, and Medicare paid $8,196.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2013-11-22.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 96372 Injection Administration | Office | 108 | 21 | $4.49 | $485 |
| 99232 Hospital E&M - Subsequent | Facility | 97 | 29 | $49.94 | $4,844 |
| 99238 Hospital Discharge Management | Facility | 21 | 16 | $55.34 | $1,162 |
| 99222 Hospital E&M - Initial | Facility | 19 | 17 | $71.59 | $1,360 |
By year: 2022 $14K for 483 services; 2023 $14K for 432 services; 2024 $8,196 for 260 services.
Medicare prescription drug claims, 2024
In 2024, the drug Mathew V Castelino prescribed most often to Medicare patients was Quetiapine Fumarate, with 558 prescriptions and refills. In total Mathew V Castelino wrote 5,821 Medicare prescriptions that cost $3.2M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Quetiapine Fumarate Generic | 558 | 601 | 82 | $9,870 |
| Escitalopram Oxalate Generic | 357 | 425 | 61 | $2,868 |
| Clonazepam Generic | 326 | 329 | 38 | $2,141 |
| Divalproex Sodium Generic | 246 | 268 | 47 | $9,026 |
| Benztropine Mesylate Generic | 220 | 242 | 26 | $2,168 |
| Hydroxyzine Pamoate Generic | 208 | 221 | 31 | $1,338 |
| Haloperidol Generic | 206 | 206 | 21 | $6,413 |
| Aripiprazole Generic | 192 | 204 | 35 | $28K |
| Trazodone Hcl Generic | 177 | 192 | 29 | $1,776 |
| Invega Sustenna Paliperidone Palmitate | 177 | 177 | 22 | $554K |
| Risperidone Generic | 162 | 183 | 18 | $2,517 |
| Divalproex Sodium Er Divalproex Sodium | 151 | 159 | 18 | $7,034 |
| Buspirone Hcl Generic | 138 | 150 | 18 | $1,725 |
| Duloxetine Hcl Generic | 138 | 148 | 15 | $3,171 |
| Lamotrigine Generic | 134 | 144 | 16 | $1,042 |
Brand drugs: - claims; generic drugs: 4,736 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Mathew V Castelino $376 ($376 in general payments such as food, travel and fees) from 11 companies. The largest payer was Lundbeck LLC with $58.87.
| Company | Payments | Amount |
|---|---|---|
| Lundbeck LLC | 3 | $58.87 |
| E.R. Squibb & Sons, L.L.C. BMY | 3 | $54.54 |
| Neurocrine BioSciences, Inc. NBIX | 3 | $45.01 |
| Otsuka America Pharmaceutical, Inc. 4578.T | 2 | $40.37 |
| Teva Pharmaceuticals USA, Inc. TEVA | 2 | $33.34 |
| Vanda Pharmaceuticals Inc. VNDA | 2 | $32.66 |
| Indivior Inc. INDV | 1 | $27.67 |
| Axsome Therapeutics, Inc. AXSM | 1 | $25.75 |
| Alkermes, Inc. ALKS | 1 | $21.39 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) JNJ | 1 | $18.57 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.